Showing: 1 - 5 of 5 RESULTS

Nickel Alloys Market Analysis, Trends, and Forecasts, 2017-2022 by SpendEdge

The Nickel Alloys market size is expected to grow over USD 2 billion at a Compound Annual Growth Rate (CAGR) of 3.2% during the forecast period of 2017-2022.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201010005004/en/

SpendEdge has announced the release of its Global Nickel Alloys Market Procurement Intelligence Report (Graphic: Business Wire)

Various end-user sectors are exhibiting their growing demand for express delivery of products which is fuelling spend growth in the Nickel Alloys market. For instance, the express delivery of products such as investigational medical products, clinical supplies, and patient samples is critical for buyers in the healthcare sector.

This report also offers market impact and new opportunities created due to the COVID-19 pandemic. Request free sample pages

Top Spending Regions in the Nickel Alloys Market:

According to the spend share and forecasts, APAC and Europe will be the leading regions in the Nickel Alloys market.

To know more about these regions and their influence in on the Nickel Alloys market Request free demo

Insights that drive the Supply chain market of Nickel Alloys Market:

  • Courier express and parcel service providers’ profit margins are expected to increase owing to the rise in adoption of cost-plus pricing and asset utilization rates.

  • In the Nickel Alloys market, service providers prefer to their services based on seasonal demand.

Some of the top Nickel Alloys suppliers listed in this report:

This Nickel Alloys procurement intelligence report has enlisted the top suppliers and their cost structures, SLA terms, best selection criteria, and negotiation strategies.

  • Aperam

  • ATI

  • Carpenter Technology

  • Thyssenkrupp

  • Haynes International

Reason to download the free sample of this report:

  • To have a better grasp over the market dynamics

  • Understand the key market trends

  • Better supplier understanding and have an edge over the negotiation

  • Know what are the factors that influence the demand-supply shifts

  • Help you interpret and use the best procurement practices in this market

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market

To get instant access to over 1000 market-ready procurement intelligence reports without any additional costs or commitment, Contact Us.

About SpendEdge:

SpendEdge shares your passion for driving sourcing and procurement excellence. We are the preferred procurement market intelligence partner for 120+ Fortune 500 firms and other leading companies across numerous industries. Our strength lies in delivering robust, real-time procurement market intelligence reports and solutions.

To know more https://www.spendedge.com/request-for-demo

View source version on businesswire.com: https://www.businesswire.com/news/home/20201010005004/en/

Contacts

SpendEdge
Anirban Choudhury
Marketing Manager
US: +1 630 984 7340
UK: +44 148 459 9299
https://www.spendedge.com/contact-us

Source Article

Mark Farrah Associates Assessed 2nd Quarter Health Insurance Enrollment Trends

Mark Farrah Associates (MFA), www.markfarrah.com, released a mid-year 2020 health insurance segment enrollment update. Based on membership data filed with statutory financial reports from the NAIC (National Association of Insurance Commissioners), the CA DMHC (California Department of Managed Health Care), and data from MFA’s ASO estimates, insurance companies provided medical coverage for 274 million people, as of June 30, 2020. This number is up from 268.2 million or approximately 5.8 million members, from a year ago.

  • Second quarter enrollment trends indicated membership gains for Individual, Medicare Advantage (MA), Managed Medicaid, and Employer-Group ASO (administrative services only for self-funded plans) business, while the Employer-Group risk segment experienced a year-over-year decline.

  • Over 15.3 million people are currently enrolled in Individual, Non-Group medical plans, representing a 2.8% increase between 2Q19 and 2Q20.

  • Managed Care Organizations (MCOs) now provide coverage for approximately 52.8 million beneficiaries, representing 6% growth, year-over-year. According to CMS reports, nearly 73.5 million people rely on Medicaid as their source of health insurance coverage.

  • Second quarter membership in Medicare Advantage (MA) plans increased to over 24.8 million, from 22.2 million in the prior year.

To read the FREE full text of “Mid-Year Trends in Health Insurance Enrollment and Segment Performance“, visit the Analysis Briefs library on Mark Farrah Associates’ website.

About Mark Farrah Associates (MFA)

Mark Farrah Associates (MFA) is a leading data aggregator and publisher providing health plan market data and analysis tools for the healthcare industry. Our product portfolio includes Health Coverage Portal™, County Health Coverage™, 5500 Employer Health Plus, Medicare Business Online™, Medicare Benefits Analyzer™, and Health Plans USA™. For more information about these products, refer to the informational videos and brochures available under the Our Products section of the website or call 724-338-4100. MFA will continue to monitor enrollment changes and competitive shifts across all healthcare segments.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201006005781/en/

Contacts

Mark Farrah Associates
Ann Marie Wolfe, amwolfe@markfarrah.com

Source Article

New York Worries Over 20 Coronavirus Hot Spots, Wisconsin Sees Troubling Trends | Top News

By Jonathan Allen and Lisa Shumaker

NEW YORK (Reuters) – New York state reported an uptick of positive coronavirus tests in 20 “hot spots” on Thursday, while Midwest states also reported rising caseloads led by Wisconsin, where U.S. President Donald Tramp will hold rallies over the weekend.

New cases of COVID-19 rose in 27 out of 50 U.S. states in September compared with August, with an increase of 111% in Wisconsin, according to a Reuters analysis.

Wisconsin is also dealing with a troubling rise in serious COVID-19 cases that threaten to overwhelm hospitals.

“Our emergency department has had several instances in the past week where it was past capacity and needed to place patients in beds in the hallways,” Bellin Health, which runs a hospital in Green Bay, said in a statement. “Our ICU (intensive care unit) beds have also been full, or nearly full, during the past week.”

Dr. Ryan Westergaard, chief medical officer at the Wisconsin department of Health Services, said the state’s outbreak started in younger people and has now spread throughout the community.

“Public gatherings of any kind are dangerous right now, more so than they have been at any time during this epidemic,” he told CNN on Thursday.

In New York, which grappled with the world’s most rampant outbreak earlier this the year, officials said they were worried about clusters of cases in 20 ZIP code areas across the state, where the average rate of positive tests rose to 6.5% from 5.5% the day before.

New York Governor Andrew Cuomo and New Jersey Governor Phil Murphy encouraged residents to download onto their smartphones a new voluntary contact-tracing app, COVID Alert, they launched on Thursday. The app uses Bluetooth technology to alert users if they have recently been near someone who later tested positive for the novel coronavirus.

Many of New York’s 20 hot spots — half of which are in New York City — include Orthodox Jewish communities. Cuomo said he talked to community leaders about enforcing social distancing measures.

“A cluster today can become community spread tomorrow,” Cuomo said on a briefing call with reporters. “These ZIP codes are not hermetically sealed.”

He implored local authorities to increase enforcement measures. “If they’re not wearing masks, they should be fined,” Cuomo said.

Wisconsin health officials are urging residents to stay home and avoid large gatherings ahead of Trump’s weekend rallies in La Crosse and Green Bay in the run up to the Nov. 3 election.

An indoor Trump rally in Tulsa, Oklahoma, in July likely contributed to a subsequent rise in cases there, city health officials said.

“This spike we’re seeing in Brown County, Wisconsin should be a wakeup call to anyone who lives here that our community is facing a crisis,” Dr. Paul Casey, medical director of the emergency department at Bellin Hospital, told CNN.

Cases, hospitalizations, positive test rates and deaths are all climbing in Wisconsin, according to a Reuters analysis.

Over the past week, 21% of coronavirus tests on average came back

Leaders in several states warn residents to be on guard as worrying Covid-19 trends emerge

Leaders in states across the country are sounding the alarm about rising Covid-19 cases that experts say could foreshadow a coming surge.



a person taking a selfie in a car: Medical technicians work at a drive-thru coronavirus disease (COVID-19) testing facility at the Regeneron Pharmaceuticals company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. Picture taken September 17, 2020. Brendan McDermid/Reuters


© Brendan McDermid/Reuters
Medical technicians work at a drive-thru coronavirus disease (COVID-19) testing facility at the Regeneron Pharmaceuticals company’s Westchester campus in Tarrytown, New York, U.S. September 17, 2020. Picture taken September 17, 2020. Brendan McDermid/Reuters

In New York, several Covid-19 clusters have created “hotspot” zip codes, the governor said, with a positivity rate about five times more than the statewide figure. The clusters are a “stark reminder” that New Yorkers need to stay vigilant, Gov. Andrew Cuomo said.

“Wear a mask, socially distance, follow the public health guidance — because this thing is not over,” Cuomo said in a statement.

Leading health officials including Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, have also warned that the US could see an especially challenging fall and winter this year. They say cities and counties should prepare by keeping safety measures and guidelines in place.

“We are still knee-deep in the first wave of this,” Fauci said in a Facebook and Twitter livestream.

In Kentucky, Gov. Andy Beshear urged the state to stop a recent “escalation” of cases after reporting more than 1,000 new infections for the second day in a row.

“Today’s daily report is too high,” the governor said. “I need your help. It’s up to us and we’ve got to get this done.”

Wisconsin reported its highest number of Covid-19 hospitalizations on record, with hospitalized patients nearly doubling in the state since September 18, according to hospital officials. And in Illinois, the governor is tightening restrictions in one part of the state after an increase in positivity rates.

At least 27 states have reported more new cases since the previous week and only nine are reporting a decline, according to data from Johns Hopkins University. Nationwide, more than 7.2 million people have been infected and more than 206,000 Americans have died.

When a vaccine could be available to US population

On Wednesday, Moderna CEO Stéphane Bancel said if its Covid-19 vaccine is proven safe and effective, it could be available to the general population by late March or early April.

Moderna began its Phase 3 clinical trial for a Covid-19 vaccine in the US in July. It’s one of four companies that have begun Phase 3 Covid-19 vaccine trials in the US — the others are Johnson & Johnson, Pfizer/BioNTech and AstraZeneca. The AstraZeneca trial was paused after an unexplained illness in a volunteer, and US health authorities are still considering crucial questions that remain around the injections of the experimental vaccine.

“I think a late Q1, early Q2 approval is a reasonable timeline, based on what we know from our vaccine,” Bancel said at a conference hosted by the Financial Times.

But there are several steps that will have to come before that.

If the safety and efficacy data checks out, Bancel says he expects Moderna will be

Regenerative Medicine Market Huge Growth Opportunities and Trends to 2025

The MarketWatch News Department was not involved in the creation of this content.

Sep 29, 2020 (Market Insight Reports) —
The Regenerative Medicine Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2020-2026. The Regenerative Medicine market report is a valuable source of data for business strategists. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data (as applicable). The report explores the current outlook in global and key regions from the perspective of players, countries, product types, and end industries. This Regenerative Medicine Market study provides comprehensive data that enhances the understanding, scope, and application of this report.

Top Companies in the Global Regenerative Medicine Market
DePuy Synthes, Osiris Therapeutics, Medtronic plc (NYSE: MDT), Stryker Corporation (NYSE: SYK), Acelity, Zimmer Biomet Holdings, Inc. (NYSE: ZBH), UniQure, MiMedx Group, Cellular Dynamics International, Organogenesis, Vericel Corporation, Mesoblast, Guanhao Biotech, Vcanbio, Cytori, Golden Meditech, Bellicum Pharmaceuticals, Celgene, Gamida Cell, Stemcell Technologies, among others.

According to this study, over the next five years, the Regenerative Medicine market will register a 24.3% CAGR in terms of revenue, the global market size will reach $ 19360 million by 2025, from $ 8118.3 million in 2019.

Market Overview:
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the “process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function”. It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds, and ocular diseases.

Get a Sample PDF Copy of the Latest Research on Regenerative Medicine Market 2020 Before the purchase
https://www.marketinsightsreports.com/reports/01301807201/global-regenerative-medicine-market-growth-status-and-outlook-2020-2025/inquiry?Mode=46&Source=MW

According to the estimation of the World Health Organization, there is an increasing prevalence of diabetes among adults over the age of 18 years, which has increased to 8.5% in 2014 compared to 4.5% in 1980 across the globe. As per the estimation of the Arthritis Foundation, the number of people expected to be diagnosed from arthritis will be more than 78 million, by 2040.

The 21st Century Cures Act, approved in December 2016, created room for the establishment of the Regenerative Medicine Innovation Project (RMIP). NIH (National Institute of Health) is leading the RMIP in coordination with the FDA. The 21st Century Cures Act approved $30 million in federal awards over four years (2020-2020) for the RMIP, thus accelerating the arena by aiding clinical research on mature stem cells while endorsing the uppermost morals for scientific research and patient safety.

Market Insights:
Currently, some companies in the world can provide regenerative medicine services, mainly concentrating in the USA. The main market